# Sulforaphane Supplementation Study

> **NCT04364360** · NA · UNKNOWN · sponsor: **University of Oxford** · enrollment: 60 (estimated)

## Conditions studied

- Non-Alcoholic Fatty Liver Disease
- Obesity
- Metabolic Syndrome

## Interventions

- **DIETARY_SUPPLEMENT:** Sulforaphane extract

## Key facts

- **NCT ID:** NCT04364360
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-01
- **Primary completion:** 2023-08
- **Final completion:** 2023-08
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2022-06-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04364360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04364360, "Sulforaphane Supplementation Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04364360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*